HLA and Celiac Disease Susceptibility: New Genetic Factors Bring Open Questions about the HLA Influence and Gene-Dosage Effects

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Medrano, Luz María ^a   Dema, Bárbara ^a   López Larios, Arturo ^a   Maluenda, Carlos ^a   Bodas, Andrés ^a   López Palacios, Natalia ^a   Figueredo, M Ángeles ^a   Fernández Arquero, Miguel ^a   Núñez, Concepción ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE CONTROL STUDY; CELIAC DISEASE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DNA EXTRACTION; FEMALE; GENE; GENE DOSAGE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HLA B8 GENE; HLA DQA1 GENE; HLA DQB1 GENE; HLA DRB1 GENE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; TUMOR NECROSIS FACTOR ALPHA GENE; TUMOR NECROSIS FACTOR BETA GENE;

CELIAC DISEASE; CHILD; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; MALE;

EID: 84868323071     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048403     Document Type: Article

References (17)

1. Keuning JJ, Pena AS, van Leeuwen A, van Hooff JP, va Rood JJ, (1976) HLA-DW3 associated with coeliac disease. Lancet 1: 506-508.
2. Baschal EE, Aly TA, Jasinski JM, Steck AK, Noble JA, et al. (2009) Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypes. Clin Immunol 132: 203-214.
3. de la Concha EG, Cavanillas ML, Cenit MC, Urcelay E, Arroyo R, et al. (2012) DRB1*03:01 Haplotypes: Differential Contribution to Multiple Sclerosis Risk and Specific Association with the Presence of Intrathecal IgM Bands. PLoS One 7: e31018.
4. Bolognesi E, Karell K, Percopo S, Coto I, Greco L, et al. (2003) Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 61: 308-316.
5. Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, et al. (2006) Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun 7: 550-554.
6. Louka AS, Lie BA, Talseth B, Ascher H, Ek J, et al. (2003) Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 55: 339-343.
7. de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, et al. (2000) Celiac disease and TNF promoter polymorphisms. Hum Immunol 61: 513-517.
8. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, et al. (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54: 136-160.
9. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL, (1991) DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol 147: 1053-1059.
10. Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, et al. (1999) Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 53: 1361-1363.
11. van Heel DA, Hunt K, Greco L, Wijmenga C, (2005) Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 19: 323-339.
12. Traherne JA, Horton R, Roberts AN, Miretti MM, Hurles ME, et al. (2006) Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet 2: e9.
13. Sollid LM, (2000) Molecular basis of celiac disease. Annu Rev Immunol 18: 53-81.
14. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, et al. (2007) A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 39: 827-829.
15. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, et al. (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A 100: 12390-12395.
16. Fallang LE, Bergseng E, Hotta K, Berg-Larsen A, Kim CY, et al. (2009) Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol 10: 1096-1101.
17. Bodd M, Kim CY, Lundin KE, Sollid LM, (2012) T-Cell Response to Gluten in Patients With HLA-DQ2.2 Reveals Requirement of Peptide-MHC Stability in Celiac Disease. Gastroenterology 142: 552-561.